Risk factors for breast cancer from benign breast disease in a diverse population
- 269 Downloads
Background The majority of studies have reported risks of breast cancer (BC) from benign breast disease (BBD) in essentially homogenous Caucasian populations. Information on breast cancer risk factors in larger, multi-ethnic populations should facilitate the development of appropriate and targeted risk reduction strategies. Design Cases and controls were drawn from a parent BBD cohort of 4,970 women, 1,341 African–Americans (AA) and 3,629 non-AA who were diagnosed with BBD after examination of an excisional breast biopsy. Risk factors (34 variables) included demographics, lesion types, and epidemiological variables. Results The final multivariable model retained significance (P < 0.05) for lesion risk-level, fibroadenoma, and the interaction of age-by-race. Women with proliferative lesions (no atypia, risk level 2) were 1.7 times more likely to develop BC when compared with women with non-proliferative lesions (OR = 1.7, 95% CI 1.13, 2.42, P = 0.009). Women with atypia (risk level 3) were 3.75 times more likely to develop BC compared to women with non-proliferative lesions (OR = 3.75, 95% CI 1.99, 7.06, P < 0.001). The odds of breast cancer was approximately 35% lower among women with fibroadenoma as compared to women without fibroadenoma (OR = 0.65, 95% CI 0.46, 0.94, P = 0.020). AA women with BBD who were 50 years or older were 2.28 times more likely to develop breast cancer as compared to non-AA women who were less than 50 years old (OR = 2.28, 95% CI 1.34, 3.88, P = 0.002). Conclusion Women with fibroadenoma (nonproliferative or proliferative) were less likely to progress to BC. Older AA women are at greater risk for progression to breast cancer from BBD.
KeywordsBenign breast disease Progression Risk factors
This research was supported by NIH CA 70923 (MJW) and ACS EDT-116 (MJW).
- 2.Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJIII, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237. doi: 10.1056/NEJMoa044383 CrossRefPubMedGoogle Scholar
- 9.Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJIII, Reynolds CA, Hartmann LC (2007) Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 25:2671–2677. doi: 10.1200/JCO.2006.09.0217 CrossRefPubMedGoogle Scholar
- 14.Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258–1265. doi:10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-IGoogle Scholar
- 15.Dupont WD, Page DL, Parl FF, Plummer WD Jr, Schuyler PA, Kasami M, Jensen RA (1999) Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer 85:1277–1283. doi:10.1002/(SICI)1097-0142(19990315)85:6<1277::AID-CNCR9>3.0.CO;2-EGoogle Scholar
- 21.Cowan DF (1989) H. T. Involution of the breast in women aged 50 to 104 years: a histopathological study of 102 cases. Surg Pathol 2:323–333Google Scholar
- 24.Henson DE, Tarone RE (1994) Involution and the etiology of breast cancer. Cancer 74:424–429. doi:10.1002/1097-0142(19941001)74:7<1974::AID-CNCR2820740724>3.0.CO;2-0Google Scholar
- 29.McDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D (1992) Histologic types of benign breast disease and the risk for breast cancer. The cancer and steroid hormone study group. Cancer 69:1408–1414. doi:10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-CGoogle Scholar
- 36.Dupont WD, Page DL, Rogers LW, Parl FF (1989) Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 63:948–957. doi:10.1002/1097-0142(19890301)63:5<948::AID-CNCR2820630527>3.0.CO;2-UGoogle Scholar
- 37.Byrne C, Connolly JL, Colditz GA, Schnitt SJ (2000) Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk. Cancer 89:2046–2052. doi:10.1002/1097-0142(20001115)89:10<2046::AID-CNCR3>3.0.CO;2-FGoogle Scholar